MDNA Life Sciences Units (Proposed)
MDLS0.000
Close 12/19, 16:00（ET）Quotes delayed by 15 min
--Market Cap
--P/E TTM
More Details of MDNA Life Sciences Units (Proposed) Company
MDNA Life Sciences Inc is a United States-based company. It develops and commercializes diagnostic tests for the detection of disease in humans. The Company's products include mitochondrial deoxyribonucleic acid (DNA) test (MDNA Test) for prostate cancer detection, mitomics test for human chorosomes, and mitomic DNA test for non-invasive uterine fibrocarcinoma (NFT). Its products are used to detect diseases such as prostate cancer, endometriosis, skin cancer and UV damage.
MDNA Life Sciences Units (Proposed) Info
Ticker SymbolMDLS
Company nameMDNA Life Sciences Inc
IPO date- -
CEOMitton (Christopher C)
Number of employees12
Security typeUnit
Fiscal year-end- -
Address2054 Vista Parkway,
CityWEST PALM BEACH
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code33411
Phone18443216362
Websitehttps://mdnalifesciences.com/
Ticker SymbolMDLS
IPO date- -
CEOMitton (Christopher C)
Company Executives of MDNA Life Sciences Units (Proposed)
Name
Name/Position
Position
Shareholding
Change
Mr. Christopher C. Mitton
Mr. Christopher C. Mitton
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jonathan Mills
Mr. Jonathan Mills
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Andrew Harbottle, Ph.D.
Dr. Andrew Harbottle, Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Ms. Jennifer Creed
Ms. Jennifer Creed
Chief Development Officer
Chief Development Officer
--
--
Mr. Robert Poulter
Mr. Robert Poulter
Chief Business Officer
Chief Business Officer
--
--
Mr. Christopher Hill
Mr. Christopher Hill
Independent Director
Independent Director
--
--
Dr. Robert Thayer, Ph.D.
Dr. Robert Thayer, Ph.D.
Independent Director
Independent Director
--
--
Mr. Harry Smart
Mr. Harry Smart
Chairman of the Board
Chairman of the Board
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Christopher C. Mitton
Mr. Christopher C. Mitton
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jonathan Mills
Mr. Jonathan Mills
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Andrew Harbottle, Ph.D.
Dr. Andrew Harbottle, Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Ms. Jennifer Creed
Ms. Jennifer Creed
Chief Development Officer
Chief Development Officer
--
--
Mr. Robert Poulter
Mr. Robert Poulter
Chief Business Officer
Chief Business Officer
--
--
Mr. Christopher Hill
Mr. Christopher Hill
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Reporting Period
No. of institutions
Shares Held
Proportion
Change
No Data
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
No Data
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of MDNA Life Sciences Units (Proposed)?
The top five shareholders of MDNA Life Sciences Units (Proposed) are:
What are the top three shareholder types of MDNA Life Sciences Units (Proposed)?
The top three shareholder types of MDNA Life Sciences Units (Proposed) are:
Other
Other
How many institutions hold shares of MDNA Life Sciences Units (Proposed) (MDLS)?
As of --, -- institutions hold shares of MDNA Life Sciences Units (Proposed), with a combined market value of approximately --, accounting for --% of the total shares. Compared to --, institutional shareholding has increased by --.
What is the biggest source of revenue for MDNA Life Sciences Units (Proposed)?
In --, the -- business generated the highest revenue for MDNA Life Sciences Units (Proposed), amounting to -- and accounting for --% of total revenue.
